(Q38466547)

3 September 2017

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma (English)

1 reference

3 September 2017

0 references

Camp RL

1

1 reference

3 September 2017

Rimm EB

series ordinal

2

1 reference

3 September 2017

Rimm DL

series ordinal

3

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

3 September 2017

1 reference

3 September 2017

86

1 reference

3 September 2017

2259-2265

1 reference

3 September 2017

11

1 reference

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Projects (NSABP). Prognostic discriminants for 8-year survival for node-negative invasive breast cancer patients

3 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

How to use prognostic factors in axillary node-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

c-met proto-oncogene expression in benign and malignant human prostate tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

Tyrosine kinase receptor indistinguishable from the c-met protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

Emerging multipotent aspects of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

The met proto-oncogene receptor and lumen formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

Expression of c-met is a strong independent prognostic factor in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11%3C2259%3A%3AAID-CNCR13%3E3.0.CO%3B2-2

10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference